Syk tyrosine kinase required for mouse viability and B-cell development - PubMed (original) (raw)
. 1995 Nov 16;378(6554):303-6.
doi: 10.1038/378303a0.
Affiliations
- PMID: 7477353
- DOI: 10.1038/378303a0
Syk tyrosine kinase required for mouse viability and B-cell development
A M Cheng et al. Nature. 1995.
Abstract
The Syk cytoplasmic protein-tyrosine kinase has two amino-terminal SH2 domains and a carboxy-terminal catalytic domain. Syk, and its close relative ZAP-70, are apparently pivotal in coupling antigen- and Fc-receptors to downstream signalling events. Syk associates with activated Fc receptors, the T cell receptor complex and the B-cell antigen-receptor complex (BCR) in immature and mature B lymphocytes. On receptor activation, the tandem SH2 domains of Syk bind dual phosphotyrosine sites in the conserved ITAM motifs of receptor signalling chains, such as the immunoglobulin alpha and beta-chains of the BCR, leading to Syk activation. Here we have investigated Syk function in vivo by generating a mouse strain with a targeted mutation in the syk gene. Homozygous syk mutants suffered severe haemorrhaging as embryos and died perinatally, indicating that Syk has a critical role in maintaining vascular integrity or in wound healing during embryogenesis. Analysis of syk-/- lymphoid cells showed that the syk mutation impaired the differentiation of B-lineage cells, apparently by disrupting signalling from the pre-BCR complex and thereby preventing the clonal expansion, and further maturation, of pre-B cells.
Similar articles
- Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.
Turner M, Mee PJ, Costello PS, Williams O, Price AA, Duddy LP, Furlong MT, Geahlen RL, Tybulewicz VL. Turner M, et al. Nature. 1995 Nov 16;378(6554):298-302. doi: 10.1038/378298a0. Nature. 1995. PMID: 7477352 - Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
Goodman PA, Wood CM, Vassilev A, Mao C, Uckun FM. Goodman PA, et al. Oncogene. 2001 Jul 5;20(30):3969-78. doi: 10.1038/sj.onc.1204515. Oncogene. 2001. PMID: 11494125 - The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes.
van Oers NS, Weiss A. van Oers NS, et al. Semin Immunol. 1995 Aug;7(4):227-36. doi: 10.1006/smim.1995.0027. Semin Immunol. 1995. PMID: 8520027 Review. - Autoinhibition and adapter function of Syk.
Kulathu Y, Grothe G, Reth M. Kulathu Y, et al. Immunol Rev. 2009 Nov;232(1):286-99. doi: 10.1111/j.1600-065X.2009.00837.x. Immunol Rev. 2009. PMID: 19909371 Review.
Cited by
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond.
Criado PR, Lorenzini D, Miot HA, Bueno-Filho R, Carneiro FRO, Ianhez M. Criado PR, et al. Inflamm Res. 2023 Jun;72(6):1257-1274. doi: 10.1007/s00011-023-01744-w. Epub 2023 May 22. Inflamm Res. 2023. PMID: 37212867 Free PMC article. Review. - Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation.
Muro R, Narita T, Nitta T, Takayanagi H. Muro R, et al. Front Immunol. 2023 Jan 12;13:1045881. doi: 10.3389/fimmu.2022.1045881. eCollection 2022. Front Immunol. 2023. PMID: 36713401 Free PMC article. - A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
Kling MJ, Kesherwani V, Mishra NK, Alexander G, McIntyre EM, Ray S, Challagundla KB, Joshi SS, Coulter DW, Chaturvedi NK. Kling MJ, et al. J Exp Clin Cancer Res. 2022 Nov 11;41(1):321. doi: 10.1186/s13046-022-02530-y. J Exp Clin Cancer Res. 2022. PMID: 36357906 Free PMC article. - A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models.
Cho S, Jang E, Yoon T, Hwang H, Youn J. Cho S, et al. Clin Exp Immunol. 2023 Mar 8;211(1):31-45. doi: 10.1093/cei/uxac096. Clin Exp Immunol. 2023. PMID: 36346114 Free PMC article. - 3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors.
Kumar V, Parate S, Danishuddin, Zeb A, Singh P, Lee G, Jung TS, Lee KW, Ha MW. Kumar V, et al. Front Cell Infect Microbiol. 2022 Jun 30;12:909111. doi: 10.3389/fcimb.2022.909111. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35846777 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous